
We delve into the ORBITA-2 trial, examining the role of Percutaneous Coronary Intervention (PCI) in managing angina in patients with stable coronary artery disease. The trial results highlight PCI's effectiveness in reducing angina symptoms, compared to a placebo, in the absence of antianginal medication. Original article here.
ABOUT THE STATE OF HEALTH
The State of Health helps you understand the most important news and research in healthcare and medicine. For more visit stateofhealth.care
FOLLOW US